The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today read our take on HRT and breast cancer, a blog post about the limits of reductionist approaches in cancer biology and our new research strategy.
Claire Bithell looks at what our latest research about HRT and breast cancer means for women.
Dr Christopher Tape ponders the limitations of a reductionist approach in cancer biology and looks at how new approaches might provide for a more holistic view of how tumours behave.
Women taking combined HRT are 2.7 times more likely to develop breast cancer than non-users, Breast Cancer Now Generations Study finds
Our new research strategy offers a bold and ambitious vision that will speed up our progress against cancer, and will confronting its ability to adapt and evolve.
We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
To achieve our aims, we need to put down strong foundations in the way we organise and support our research.
We will overcome the challenges posed by cancer’s complexity, adaptability and evolution through scientific and clinical excellence, innovation and partnership.
We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
We need your help to better understand how cancer develops when the complex process of cell division goes wrong.
Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
For more than 100 years, the ICR has played an important role in shaping understanding of cancer and how it can be treated.
See what life is like as a student at The Institute of Cancer Research, the UK’s leading academic research centre.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
The ICR is the top-ranked academic research centre in the UK after coming first overall in the 2014 Research Excellence Framework.
Did you know that The @ChrisLucasTrust has raised over £1 million for research into rhabdomyosarcoma? https://t.co/e669Uy3zkK
Escape from reductionist valley
What should women know about the new HRT and breast cancer study?